| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $282K | — | +16.7% |
| Cost of Revenue | $198K | — | +38.5% |
| Gross Profit | $84K | — | -15.0% |
| R&D Expense | $6K | — | -72.2% |
| SG&A Expense | $61K | — | -30.0% |
| Operating Income | -$140K | — | -11.7% |
| Interest Expense | $150K | — | +13.3% |
| Pre-tax Income | $549K | — | +20.2% |
| Net Income | $549K | — | +20.2% |
| EPS (Basic) | $0.00 | — | — |
| EPS (Diluted) | $0.00 | — | — |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $90K | +124.8% | +29.4% |
| Accounts Receivable | $17K | -60.8% | +721.9% |
| Current Assets | $106K | +29.1% | +40.8% |
| Total Assets | $545K | -19.9% | -49.0% |
| Current Liabilities | $8.1M | -10.9% | +83.6% |
| Total Liabilities | $8.2M |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$177K | — | -217.5% |
| Investing Cash Flow | $100K | — | +172.6% |
| Financing Cash Flow | $127K | — | -44.5% |
| +81.4% |
| Stockholders' Equity | -$7.6M | +10.1% | -121.8% |